Use of proton pump inhibitors appears to increase the risk for kidney failure among patients with CKD. Use of proton pump inhibitors (PPIs) may spur progression to kidney failure in patients with ...

Proton-pump inhibitors (PPIs) are the most effective medical therapy for patients with moderate-to-severe GERD and are widely prescribed to pregnant women. However, safety data about the use of ...

Objectives The widespread use of proton pump inhibitors (PPIs) raised concerns on the safety of long-term use of these drugs. Community pharmacists have great responsibility of educating patients on ...

This study aims to analyze the existence of information about deprescription in the leaflets of proton pump inhibitor (PPI) medications. The leaflets available on the Brazilian Health Regulatory ...

Objective To determine whether proton pump inhibitors (PPIs) are associated with an increased risk of colorectal cancer, compared with histamine-2 receptor antagonists (H2RAs). Design The United ...

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...

Expert Rev Clin Pharmacol. 2013;6(4):443-451.

Unconventional Computing Laboratory, University of the West of England, Bristol BS16 1QY, U.K.